Atherosclerosis, ischemia, and anticancer drugs

The heart is affected by cardiotoxicity of anticancer drugs. Myocardium, pericardium and endocardium can be affected. Besides these coronary arteries can be affected by accelerated atherosclerosis. Various pathogenic mechanisms have been proposed that underlie the ischemic complications of anticance...

Full description

Saved in:
Bibliographic Details
Published inHeart views Vol. 22; no. 2; pp. 127 - 133
Main Authors Singh, Shailesh, Singh, Katyayni
Format Journal Article
LanguageEnglish
Published Doha Wolters Kluwer India Pvt. Ltd 01.04.2021
Medknow Publications and Media Pvt. Ltd
Medknow Publications & Media Pvt. Ltd
Wolters Kluwer - Medknow
Wolters Kluwer Medknow Publications
Subjects
accelerated atherosclerosis
anticancer drugs
Antimitotic agents
Antineoplastic agents
Atherosclerosis
Cancer
cardio-oncology
coronary artery disease
Drugs
Ischemia
myocardial infarction
Nilotinib
Pericardium
Review
Stents
coronary artery disease
cardio-oncology
Accelerated atherosclerosis
anticancer drugs
myocardial infarction
Online AccessGet full text

Cover

More Information
Summary:The heart is affected by cardiotoxicity of anticancer drugs. Myocardium, pericardium and endocardium can be affected. Besides these coronary arteries can be affected by accelerated atherosclerosis. Various pathogenic mechanisms have been proposed that underlie the ischemic complications of anticancer drugs. In this review we discuss the atherosclerotic and ischemic complications of anticancer drugs.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ISSN:1995-705X
0976-5123
DOI:10.4103/HEARTVIEWS.HEARTVIEWS_45_20